Question · asked by 1 review

Autologous blood or PRP vs placebo at 3 months' follow‐up: Adverse events (pain and swelling at injection site and limitation of elbow movement following injection)

Autologous blood or PRP showed no clear difference in adverse events (pain and swelling at injection site and limitation… compared with placebo at 3 months' follow‐up (low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Autologous blood or PRP vs placebo at 3 months' follow‐up
Adverse events (pain and swelling at injection site and limitation of elbow movement following injection) · lateral elbow pain
Autologous blood or PRP showed no clear difference in adverse events (pain and swelling at injection site and limitation… compared with placebo at 3 months' follow‐up (low certainty).
Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain (2021) · Cochrane Headline outcomes only
RR 1.14 [0.76, 1.72]5 studies · 425 participantsLow

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain
2021 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.